Treatment of tuberculosis using immunomodulator compounds

Details Treatment of tuberculosis using immunomodulator compounds Treatment of tuberculosis using immunomodulator compounds

2007-02-06

2007-02-06

Russel, Jeffrey Edwin (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S002600, C530S332000, C548S495000

Reexamination Certificate

active

10485487

ABSTRACT:
Tuberculosis in an animal is treated by administration of a therapeutically effective amount of an immunomodulator of formula A. In formula (A), n is 1 or 2, R is hydrogen, acyl, alkyl or a peptide fragment, and X is an aromatic or heterocyclic amino acid or a derivative. The animal may be a mammal such as a human

REFERENCES:
patent: 4520196 (1985-05-01), Wei
patent: 5212192 (1993-05-01), Raeymaekers et al.
patent: 5916878 (1999-06-01), Kolobov et al.
patent: 6060452 (2000-05-01), Green et al.
patent: 6124098 (2000-09-01), Heym et al.
patent: 6509151 (2003-01-01), Riley
patent: WO 94/20063 (1994-09-01), None
patent: WO 97/19691 (1997-06-01), None
patent: WO 97/21444 (1997-06-01), None
Database Imsdrugnews, R & D Focus Drug News, XP-002377619, Sep. 6, 1999.
Database Cin, Other Research News, XP-002377620, Feb. 28, 2000.
Database Imsdrugnews, R & D Focus Drug News, XP-002377621, Jan. 22, 2001.

Affiliated with

Also associated with

Rating

Treatment of tuberculosis using immunomodulator compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of tuberculosis using immunomodulator compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of tuberculosis using immunomodulator compounds will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3856230